Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA: 600222)
China
· Delayed Price · Currency is CNY 5.53
+0.12 (2.22%)
Dec 6, 2024, 3:00 PM CST
Henan Taloph Pharmaceutical Stock Co.,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 1,963 | 2,065 | 1,945 | 1,602 | 1,416 | 1,311 | Upgrade
|
| Other Revenue | 4.95 | 4.95 | 15.33 | 2.83 | 1.4 | 0.62 | Upgrade
|
| Revenue | 1,968 | 2,070 | 1,961 | 1,605 | 1,417 | 1,312 | Upgrade
|
| Revenue Growth (YoY) | -6.58% | 5.57% | 22.20% | 13.23% | 8.03% | 9.79% | Upgrade
|
| Cost of Revenue | 1,416 | 1,508 | 1,492 | 1,148 | 1,046 | 830.09 | Upgrade
|
| Gross Profit | 551.71 | 561.55 | 468.4 | 456.85 | 370.88 | 481.72 | Upgrade
|
| Selling, General & Admin | 323.01 | 339.5 | 317.51 | 246.89 | 211.37 | 293.07 | Upgrade
|
| Research & Development | 102.81 | 127.71 | 116.52 | 56.5 | 63.66 | 59.39 | Upgrade
|
| Other Operating Expenses | 8.51 | 6.54 | 8.42 | 2.59 | 7.08 | -2.66 | Upgrade
|
| Operating Expenses | 445.25 | 485.6 | 476.27 | 331.51 | 294.65 | 364.93 | Upgrade
|
| Operating Income | 106.46 | 75.94 | -7.87 | 125.34 | 76.23 | 116.8 | Upgrade
|
| Interest Expense | -56.77 | -54.37 | -64.63 | -83.84 | -74.44 | -68.59 | Upgrade
|
| Interest & Investment Income | 2.28 | 2.17 | 2.22 | 6.74 | 12.06 | 11.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 9.49 | 10.8 | -1.56 | -2.46 | -3.44 | -9.07 | Upgrade
|
| EBT Excluding Unusual Items | 61.46 | 34.54 | -71.84 | 45.78 | 10.4 | 50.22 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.09 | -6.42 | -11.87 | -10.17 | 2.38 | -0.28 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.2 | 0.54 | 0.03 | -1.57 | 0.2 | 0 | Upgrade
|
| Asset Writedown | 9.32 | - | -0.15 | -29.9 | - | -2.62 | Upgrade
|
| Legal Settlements | - | - | -11.61 | -1.62 | - | - | Upgrade
|
| Other Unusual Items | 14.31 | 14.31 | 12.59 | 4.93 | 16.25 | - | Upgrade
|
| Pretax Income | 88.37 | 42.96 | -82.85 | 7.45 | 29.24 | 47.32 | Upgrade
|
| Income Tax Expense | -5.92 | -1.87 | -7.09 | 0.67 | 1.64 | 4.75 | Upgrade
|
| Earnings From Continuing Operations | 94.3 | 44.83 | -75.76 | 6.78 | 27.6 | 42.57 | Upgrade
|
| Minority Interest in Earnings | -4.92 | -1.27 | 3.56 | -0.78 | 1.65 | 1.85 | Upgrade
|
| Net Income | 89.38 | 43.56 | -72.2 | 6 | 29.24 | 44.41 | Upgrade
|
| Net Income to Common | 89.38 | 43.56 | -72.2 | 6 | 29.24 | 44.41 | Upgrade
|
| Net Income Growth | - | - | - | -79.50% | -34.16% | - | Upgrade
|
| Shares Outstanding (Basic) | 557 | 563 | 562 | 560 | 547 | 556 | Upgrade
|
| Shares Outstanding (Diluted) | 557 | 563 | 562 | 560 | 547 | 556 | Upgrade
|
| Shares Change (YoY) | -1.13% | 0.07% | 0.36% | 2.52% | -1.68% | -3.16% | Upgrade
|
| EPS (Basic) | 0.16 | 0.08 | -0.13 | 0.01 | 0.05 | 0.08 | Upgrade
|
| EPS (Diluted) | 0.16 | 0.08 | -0.13 | 0.01 | 0.05 | 0.08 | Upgrade
|
| EPS Growth | - | - | - | -80.00% | -33.04% | - | Upgrade
|
| Free Cash Flow | -23.28 | 0.6 | -191.03 | 60.58 | 0.77 | -66.15 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | 0.00 | -0.34 | 0.11 | 0.00 | -0.12 | Upgrade
|
| Dividend Per Share | 0.018 | 0.018 | - | 0.010 | 0.016 | - | Upgrade
|
| Dividend Growth | - | - | - | -37.50% | - | - | Upgrade
|
| Gross Margin | 28.04% | 27.13% | 23.89% | 28.47% | 26.17% | 36.72% | Upgrade
|
| Operating Margin | 5.41% | 3.67% | -0.40% | 7.81% | 5.38% | 8.90% | Upgrade
|
| Profit Margin | 4.54% | 2.10% | -3.68% | 0.37% | 2.06% | 3.39% | Upgrade
|
| Free Cash Flow Margin | -1.18% | 0.03% | -9.74% | 3.78% | 0.05% | -5.04% | Upgrade
|
| EBITDA | 160.05 | 126.81 | 39.37 | 169.33 | 117.65 | 154.98 | Upgrade
|
| EBITDA Margin | 8.13% | 6.13% | 2.01% | 10.55% | 8.30% | 11.81% | Upgrade
|
| D&A For EBITDA | 53.6 | 50.87 | 47.24 | 43.99 | 41.42 | 38.18 | Upgrade
|
| EBIT | 106.46 | 75.94 | -7.87 | 125.34 | 76.23 | 116.8 | Upgrade
|
| EBIT Margin | 5.41% | 3.67% | -0.40% | 7.81% | 5.38% | 8.90% | Upgrade
|
| Effective Tax Rate | - | - | - | 9.01% | 5.62% | 10.04% | Upgrade
|
| Revenue as Reported | 1,968 | 2,070 | 1,961 | 1,605 | 1,417 | 1,312 | Upgrade
|
| Advertising Expenses | - | 35.78 | 39.78 | 24.05 | 14.17 | 10.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.